Desvenlafaxine Extended-Release Tablets 25 mg, 50 mg, 100 mg Suppliers & Bulk Manufacturers
Available Forms: Extended-Release Tablets
Available Strengths: 25 mg, 50 mg, 100 mg
Reference Brands: Pristiq®(US & EU), Khedezla®(US)
Category: Psychiatry / Mental Health
Desvenlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that enhances neurotransmitter levels to help regulate mood and emotional balance. It is primarily used for the treatment of major depressive disorder (MDD) in adults. The extended-release formulation ensures once-daily dosing, providing consistent therapeutic effects with improved adherence and reduced dosing frequency.
Product Description:
In the United States, desvenlafaxine extended-release tablets are FDA-approved for the treatment of major depressive disorder (MDD) in adults. As an SNRI, it requires a Boxed Warning regarding the risk of suicidal thoughts and behaviors in young individuals. Regulatory compliance includes GMP manufacturing, bioequivalence studies for generics, and ongoing post-marketing surveillance. Labeling must reflect FDA-approved indications, dosing, and adverse effects. In the European Union, desvenlafaxine is not widely marketed, but regulatory pathways exist for national or decentralized approval. Applications must include clinical efficacy, pharmacovigilance plans, and Risk Management Plans (RMPs). For compliant global sourcing, visit Pharmatradz.com. .
Desvenlafaxine Extended-Release Tablets — third party manufacturing & bulk supply
Desvenlafaxine Extended-Release Tablets 25 mg, 50 mg, 100 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Desvenlafaxine Extended-Release Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Desvenlafaxine Extended-Release Tablets →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Desvenlafaxine is used to treat major depressive disorder (MDD) in adults. It helps improve mood, reduce feelings of sadness, and alleviate other depressive symptoms such as loss of interest, fatigue, and difficulty concentrating.
Desvenlafaxine is a synthetic pharmaceutical compound that acts as a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by increasing the levels of serotonin and norepinephrine in the brain to restore neurotransmitter balance and relieve depressive symptoms.
Desvenlafaxine is marketed under brand names such as Pristiq and other regional generics.
Desvenlafaxine (Pristiq) is manufactured and marketed by Pfizer Inc. and distributed in multiple countries through authorized partners.
The generic name is Desvenlafaxine.
The most recognized brand name is Pristiq.
Desvenlafaxine is manufactured in regulated pharmaceutical facilities that comply with international quality and safety standards, including sites in the United States and other approved markets.
Related Products
Agomelatine
Strength:
25 mg, 50 mg
Form: Tablets
Reference Brands: Valdoxan (EU/UK), Thymanax (India/ Middle East)
View Details
Bupropion Hydrobromide
Strength:
75 mg, 100 mg, 150mg, 300 mg
Form: Tablets
Reference Brands: Wellbutrin (USA), Zyban (USA)
View Details
Brexpiprazole Tablets
Strength:
0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg
Form: Tablets
Reference Brands: Rexulti®(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
